Vr Adviser, LLC Gh Research PLC Transaction History

Vr Adviser, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$5.26 - $11.04 $7.5 Million - $15.7 Million	-1,425,798 Reduced 51.96%	1,318,327 $7.65 Million
Q3 2023 Nov 14, 2023	SELL	$9.8 - $14.15 $7.58 Million - $10.9 Million	-773,000 Reduced 21.98%	2,744,125 $27.6 Million
Q4 2022 May 15, 2023	BUY	$9.2 - $13.5 $1.69 Million - $2.48 Million	183,971 Added 5.52%	3,517,125 $34.2 Million
Q4 2022 Feb 14, 2023	BUY	$9.2 - $13.5 $1.69 Million - $2.48 Million	183,971 Added 5.52%	3,517,125 $34.2 Million
Q3 2022 May 15, 2023	BUY	$10.15 - $16.15 $1.5 Million - $2.38 Million	147,581 Added 4.63%	3,333,154 $38.7 Million
Q3 2022 Nov 14, 2022	BUY	$10.15 - $16.15 $1.5 Million - $2.38 Million	147,581 Added 4.63%	3,333,154 $38.7 Million
Q2 2022 May 15, 2023	SELL	$8.99 - $19.87 $2.98 Million - $6.59 Million	-331,552 Reduced 9.43%	3,185,573 $31.8 Million
Q2 2022 Aug 15, 2022	BUY	$8.99 - $19.87 $10.2 Million - $22.5 Million	1,134,513 Added 55.31%	3,185,573 $31.8 Million
Q1 2022 May 16, 2022	BUY	$15.48 - $23.98 $450,081 - $697,218	29,075 Added 1.44%	2,051,060 $37.5 Million
Q4 2021 Feb 14, 2022	BUY	$14.1 - $27.9 $5.35 Million - $10.6 Million	379,689 Added 23.12%	2,021,985 $47.2 Million
Q3 2021 Nov 15, 2021	BUY	$16.51 - $23.68 $6.05 Million - $8.68 Million	366,465 Added 28.72%	1,642,296 $36.2 Million
Q2 2021 Aug 13, 2021	BUY	$19.25 - $21.73 $24.6 Million - $27.7 Million	1,275,831 New	1,275,831 $27.7 Million

27.8M

2.8K

3.8K

Ticker GHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,020,800
Market Cap $380M
Description
GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies for the treatment of psychiatric and neurological disorders. The company focuses on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD). Its lead program is GH0...

Get notified when there are updates to the investment portfolio of Vr Adviser, LLC, based on Form 13F filings with the SEC.

Stay updated on Vr Adviser, LLC with notifications on news.